Marksans Pharma Limited has informed the Exchange regarding 'DISCLOSURE UNDER 100 DAY CAMPAIGN - "SAKSHAM NIVESHAK"'.
MARKSANS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Marksans Pharma has informed shareholders about a government-led 100 Day Campaign called 'Saksham Niveshak' initiated by the Ministry of Corporate Affairs (letter dated 16 July 2025). The campaign aims to help shareholders claim unclaimed dividends from FY2017-18 onwards before they are transferred to the Investor Education and Protection Fund (IEPF), and to update their KYC, contact, bank, and nomination details. Shareholders holding shares in physical form must submit forms ISR-1, ISR-2, ISR-3, SH-13, and SH-14 along with supporting documents to the company's Registrar (Bigshare Services). Shareholders holding shares in demat form should update details with their depository participants. The deadline to submit documents or claims is October 31, 2025.
This is a routine regulatory and shareholder-engagement notice, not a material business event — no direct impact on stock price is expected. However, shareholders who have not claimed dividends from FY2017-18 or have outdated KYC details should act promptly to avoid their unclaimed dividends being permanently transferred to the IEPF.